Overview
SEPN market data
Price History
SEPN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.10 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.58 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $10.62 – $38.04 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.5K · P/B 3.27 · P/S 21.19.
Company News
DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On TuesdayBenzinga · Jul 7, 2026, 2:05 PM
Guggenheim Maintains Buy on Septerna, Lowers Price Target to $45Benzinga · Jul 1, 2026, 1:05 PM
HC Wainwright & Co. Reiterates Buy on Septerna, Maintains $40 Price TargetBenzinga · Jul 1, 2026, 12:25 PM
Truist Securities Maintains Buy on Septerna, Raises Price Target to $43Benzinga · Jul 1, 2026, 12:00 PM
Raymond James Maintains Strong Buy on Septerna, Raises Price Target to $53Benzinga · Jun 8, 2026, 6:00 PM
Septerna Announces First Detailed Preclinical Characterization Of SEP-479 Accepted For Oral Presentation At ENDO 2026Benzinga · Jun 8, 2026, 12:10 PM